Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 03 04:00PM ET
318.55
Dollar change
+1.80
Percentage change
0.57
%
IndexS&P 500 P/E138.09 EPS (ttm)2.31 Insider Own5.43% Shs Outstand75.30M Perf Week3.35%
Market Cap24.04B Forward P/E55.80 EPS next Y5.71 Insider Trans-2.66% Shs Float71.36M Perf Month3.82%
Income174.23M PEG7.98 EPS next Q0.95 Inst Own79.24% Short Float3.18% Perf Quarter23.95%
Sales1.56B P/S15.38 EPS this Y6.51% Inst Trans2.57% Short Ratio4.46 Perf Half Y53.78%
Book/sh21.41 P/B14.88 EPS next Y29.47% ROA5.54% Short Interest2.27M Perf Year44.22%
Cash/sh17.53 P/C18.18 EPS next 5Y17.30% ROE12.10% 52W Range175.37 - 329.87 Perf YTD23.31%
Dividend Est.- P/FCF185.43 EPS past 5Y35.57% ROI7.50% 52W High-3.43% Beta0.95
Dividend TTM- Quick Ratio2.66 Sales past 5Y30.13% Gross Margin61.11% 52W Low81.65% ATR (14)7.34
Dividend Ex-Date- Current Ratio3.00 EPS Y/Y TTM13.27% Oper. Margin9.90% RSI (14)62.91 Volatility1.96% 2.59%
Employees3330 Debt/Eq0.44 Sales Y/Y TTM31.38% Profit Margin11.14% Recom1.38 Target Price330.18
Option/ShortYes / Yes LT Debt/Eq0.44 EPS Q/Q87.59% Payout0.00% Rel Volume0.55 Prev Close316.75
Sales Surprise2.73% EPS Surprise31.24% Sales Q/Q28.56% EarningsMay 06 AMC Avg Volume508.79K Price318.55
SMA203.63% SMA503.75% SMA20030.56% Trades Volume278,923 Change0.57%
Date Action Analyst Rating Change Price Target Change
Apr-10-24Reiterated Needham Buy $315 → $400
Mar-13-24Initiated Argus Buy $380
Aug-22-23Initiated Morgan Stanley Equal-Weight $230
Jul-05-23Resumed JP Morgan Overweight $236
May-11-23Upgrade JP Morgan Neutral → Overweight $236
Mar-08-23Initiated Goldman Buy $263
Mar-02-23Downgrade JP Morgan Overweight → Neutral $224
Feb-17-23Downgrade Raymond James Strong Buy → Outperform $223
Sep-15-22Initiated Barclays Overweight $147
May-23-22Downgrade Morgan Stanley Overweight → Equal-Weight $120
Today 08:38AM
May-01-24 09:15AM
Apr-29-24 06:00PM
10:00AM
Apr-28-24 09:20AM
09:30AM Loading…
Apr-26-24 09:30AM
Apr-25-24 09:00AM
Apr-23-24 09:30AM
Apr-22-24 06:00PM
04:01PM
Apr-19-24 12:10PM
09:45AM
Apr-16-24 06:00PM
Apr-11-24 09:30AM
09:00AM
04:49PM Loading…
Apr-10-24 04:49PM
01:57PM
10:05AM
Apr-09-24 06:00PM
Apr-01-24 09:30AM
Mar-29-24 09:00AM
Mar-28-24 11:30AM
Mar-27-24 09:06AM
Mar-25-24 11:12PM
10:41PM
Mar-22-24 05:50PM
Mar-20-24 06:00PM
Mar-18-24 09:00AM
Mar-15-24 08:32AM
Mar-05-24 09:00AM
10:57AM Loading…
Mar-01-24 10:57AM
Feb-29-24 02:32PM
08:55AM
Feb-28-24 04:11PM
02:37PM
02:00PM
12:50PM
11:49AM
11:49AM
10:35AM
05:52AM
Feb-27-24 06:00PM
05:02PM
04:42PM
04:12PM
04:01PM
10:16AM
Feb-20-24 05:50PM
Feb-15-24 11:41AM
09:00AM
Feb-13-24 04:01PM
Feb-12-24 05:50PM
Feb-10-24 06:39AM
Feb-05-24 05:50PM
Feb-02-24 01:40PM
Feb-01-24 09:00AM
07:00AM
Jan-30-24 05:50PM
01:18PM
Jan-26-24 08:00AM
Jan-25-24 04:05PM
Jan-24-24 05:50PM
Jan-18-24 06:00PM
Jan-17-24 09:00AM
Jan-05-24 09:00AM
Jan-03-24 06:00PM
Jan-02-24 09:30AM
Dec-26-23 10:53AM
Dec-22-23 09:30AM
Dec-21-23 01:01PM
Dec-18-23 12:17PM
Dec-16-23 07:40AM
Dec-14-23 09:40AM
09:00AM
07:04AM
Dec-12-23 07:30AM
Dec-08-23 06:42PM
Dec-07-23 11:31AM
Dec-06-23 07:05AM
Dec-03-23 06:45AM
Dec-01-23 09:30AM
Nov-30-23 09:00AM
06:30AM
Nov-28-23 04:01PM
02:30PM
12:00PM
Nov-23-23 12:20PM
Nov-22-23 07:04AM
Nov-21-23 05:30AM
Nov-20-23 11:56AM
08:35AM
Nov-17-23 06:49PM
Nov-16-23 09:00AM
Nov-13-23 02:00PM
Nov-10-23 06:58PM
Nov-08-23 07:06PM
05:55PM
10:52AM
09:34AM
12:03AM
Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Isner JoshuaPRESIDENTJan 02 '24Sale251.6835,4008,909,327309,564Jan 04 04:36 PM
Kunins Jeffrey CCPO & CTODec 19 '23Sale256.952,722699,410226,083Dec 20 06:48 PM
Isner JoshuaPRESIDENTDec 19 '23Sale257.132,562658,778344,964Dec 20 06:46 PM
Isner JoshuaPRESIDENTDec 18 '23Sale253.461,956495,775347,526Dec 20 06:46 PM
Kunins Jeffrey CCPO & CTODec 18 '23Sale253.461,796455,218228,805Dec 20 06:48 PM
Bagley BrittanyCOO & CFODec 14 '23Sale250.265,0001,251,291110,752Dec 18 04:18 PM
Isner JoshuaPRESIDENTDec 05 '23Sale233.593,653853,313349,482Dec 05 06:32 PM
Kunins Jeffrey CCPO & CTODec 05 '23Sale230.872,690621,041230,601Dec 05 06:35 PM
Kunins Jeffrey CCPO & CTODec 04 '23Sale230.792,729629,838233,291Dec 05 06:35 PM
Isner JoshuaPRESIDENTDec 04 '23Sale229.601,400321,445353,135Dec 05 06:32 PM
Kunins Jeffrey CCPO & CTODec 01 '23Sale230.38635146,289236,020Dec 05 06:35 PM
Isner JoshuaPRESIDENTDec 01 '23Sale230.3826059,898356,229Dec 05 06:32 PM
Bagley BrittanyCOO & CFONov 20 '23Sale225.615,0001,128,050115,752Nov 21 04:37 PM
Bagley BrittanyCOO & CFONov 17 '23Sale223.795,0001,118,960120,752Nov 21 04:37 PM
Kunins Jeffrey CCPO & CTONov 10 '23Sale217.3341,1678,946,820236,655Nov 13 04:41 PM
Isner JoshuaPRESIDENTOct 02 '23Sale196.3729,6995,831,990356,489Oct 04 07:11 PM
Cullivan Julie ADirectorSep 11 '23Sale214.47515110,4525,367Sep 12 08:16 PM
Isner JoshuaPRESIDENTJul 03 '23Sale193.1026,8835,191,179290,965Jul 05 06:14 PM
Kunins Jeffrey CCPO & CTOJul 03 '23Sale193.1222,9004,422,512241,076Jul 05 06:11 PM
Partovi HadiDirectorJun 23 '23Buy191.1025,0004,777,388413,817Jun 26 03:03 PM
Isner JoshuaCHIEF OPERATING OFFICERJun 16 '23Sale203.631,955398,097317,848Jun 16 04:34 PM
Isner JoshuaCHIEF OPERATING OFFICERJun 15 '23Sale196.881,482291,776319,803Jun 16 04:34 PM
Cullivan Julie ADirectorMay 30 '23Sale196.001,180231,2805,882May 31 05:03 PM
Partovi HadiDirectorMay 25 '23Buy190.7510,0001,907,471388,817May 25 03:16 PM
Cullivan Julie ADirectorMay 22 '23Sale197.582,013397,7297,062May 23 05:38 PM
Partovi HadiDirectorMay 17 '23Buy200.0210,0002,000,198378,817May 17 07:49 PM
Bagley BrittanyCFO & CBOMay 17 '23Buy200.0025050,000109,174May 17 07:51 PM
Last Close
May 03 04:00PM ET
94.40
Dollar change
+1.07
Percentage change
1.15
%
HAE Haemonetics Corp. daily Stock Chart
IndexRUT P/E38.30 EPS (ttm)2.46 Insider Own0.98% Shs Outstand50.45M Perf Week3.75%
Market Cap4.79B Forward P/E21.44 EPS next Y4.40 Insider Trans0.00% Shs Float50.29M Perf Month11.20%
Income126.57M PEG3.19 EPS next Q0.89 Inst Own100.98% Short Float4.45% Perf Quarter23.69%
Sales1.27B P/S3.77 EPS this Y30.66% Inst Trans-0.61% Short Ratio4.59 Perf Half Y9.27%
Book/sh18.57 P/B5.08 EPS next Y11.21% ROA6.21% Short Interest2.24M Perf Year15.42%
Cash/sh3.82 P/C24.72 EPS next 5Y12.00% ROE14.72% 52W Range70.74 - 95.26 Perf YTD10.40%
Dividend Est.- P/FCF37.57 EPS past 5Y21.43% ROI7.03% 52W High-0.90% Beta0.40
Dividend TTM- Quick Ratio1.76 Sales past 5Y5.50% Gross Margin51.78% 52W Low33.45% ATR (14)2.14
Dividend Ex-Date- Current Ratio2.92 EPS Y/Y TTM32.86% Oper. Margin15.76% RSI (14)76.15 Volatility1.99% 2.37%
Employees3034 Debt/Eq0.92 Sales Y/Y TTM12.48% Profit Margin9.97% Recom1.71 Target Price105.83
Option/ShortYes / Yes LT Debt/Eq0.91 EPS Q/Q-5.58% Payout0.00% Rel Volume0.76 Prev Close93.33
Sales Surprise4.80% EPS Surprise10.46% Sales Q/Q10.14% EarningsMay 09 BMO Avg Volume487.44K Price94.40
SMA208.75% SMA5015.51% SMA20011.11% Trades Volume368,663 Change1.15%
Date Action Analyst Rating Change Price Target Change
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jan-21-21Downgrade Barrington Research Outperform → Mkt Perform
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
06:30AM Loading…
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
01:26PM Loading…
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
09:30AM
07:10AM
06:33AM
06:10AM
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
04:05PM Loading…
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Oct-11-23 12:00PM
11:13AM
08:23AM
Oct-10-23 06:00AM
06:00AM
Oct-09-23 08:35AM
Oct-06-23 07:48AM
Oct-05-23 04:05PM
11:16AM
09:51AM
08:32AM
08:25AM
Oct-04-23 09:50AM
09:40AM
08:47AM
Oct-03-23 11:11AM
08:56AM
Sep-29-23 09:45AM
08:49AM
08:32AM
Sep-28-23 10:37AM
09:06AM
Sep-27-23 09:12AM
07:47AM
Sep-26-23 11:10AM
11:06AM
08:02AM
Sep-25-23 11:40AM
09:45AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strong Stewart WPresident, Global HospitalSep 12 '23Sale90.6522820,66816,221Sep 13 04:19 PM
Lingamneni AnilaEVP, Chief Technology OfficerSep 11 '23Sale90.002,305207,45014,495Sep 13 04:20 PM
Dockendorff Charles JDirectorSep 05 '23Sale87.6810,215895,6512,226Sep 07 04:23 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Option Exercise57.104,928281,39023,391Jul 20 04:17 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Sale90.004,928443,52018,463Jul 20 04:17 PM
Simon, ChristopherPresident & CEOJun 29 '23Option Exercise28.61196,7465,629,887414,113Jun 30 04:17 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Option Exercise56.936,893392,41924,040Jun 09 04:16 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Sale88.042,538223,44616,449Jun 09 04:16 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 30 '23Sale83.332,304191,99216,800Jun 01 04:19 PM